Metropolis

Metropolis Healthcare Share Price Target at Rs 2,050: Emkay Research

Metropolis Healthcare Share Price Target at Rs 2,050: Emkay Research

Emkay Research has issued a BUY recommendation on Metropolis Healthcare, setting a 12-month target price of Rs 2,050.

Metropolis Healthcare to Acquire Core Diagnostics in a Strategic Rs 247 Crore Deal

Metropolis Healthcare to Acquire Core Diagnostics in a Strategic Rs 247 Crore Deal

Metropolis Healthcare, a leading diagnostic chain in India, has announced its acquisition of Core Diagnostics for ₹247 crore.

Jay Thakkar: BUY Metropolis and REC

Jay Thakkar: BUY Metropolis and REC

Market expert Jay Thakkar from ShareKhan has suggested two BUY Calls and no SELL Call for today’s trading session.

Jay Thakkar: BUY Metropolis Healthcare, Triveni Engineering and V-Guard Industries

Jay Thakkar: BUY Metropolis Healthcare, Triveni Engineering and V-Guard Industries

Market expert Jay Thakkar from Sharekhan has suggested three BUY Calls for short term traders. Indian markets were trading firm in the afternoon session on Tuesday.

Varun Dubey: BUY Infosys, Mrs Bector Foods, Gabriel India; SELL Metropolis

Varun Dubey: BUY Infosys, Mrs Bector Foods, Gabriel India; SELL Metropolis

Market expert Varun Dubey has suggested three BUY Calls and one SELL Call for today’s trading session.

Brokerages: BUY Metropolis Healthcare, Dr Lal Path Labs, Blue Star and Ashok Leyland

Brokerages: BUY Metropolis Healthcare, Dr Lal Path Labs, Blue Star and Ashok Leyland

Indian markets are trading near their all-time highs and market sentiment is bullish.

Pages